In conclusion, abdominal obesity, insulin resistance, elevated CRP levels, hyperglycemia, hypertriglyceridemia, and higher heart/pulse rates should all be considered potential harbingers of adverse cardiometabolic outcomes. This evidence concerns the gene CRP and Hyperglycemia.